"uuid:ID","name","id","description","text","instanceType","label"
"95728471-9d5b-47fb-93ea-e3676dc72ec2","OBJ1","Objective_1","Main objective","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Objective",""
"a6e49655-7435-45e5-90d6-3561077e5b5e","OBJ2","Objective_2","Safety","To document the safety profile of the xanomeline TTS.","Objective",""
"12423089-0885-4067-b6c0-7be75d514c86","OBJ3","Objective_3","Behaviour","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Objective",""
